AG

Anand Ganpatbhai Trivedi

Active Director Director DIN 03040899
DIN 03040899 First appointment Oct 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Oct 2017
Shareholding value •••• Premium profile

About Anand Ganpatbhai Trivedi

Data last updated:

Anand Ganpatbhai Trivedi is a Director at S.G.Biopharm Private Limited (since 2018), Designated Partner at Ambix Healthcare Llp (since 2020) and Director at Pharmachem Biotech (I) Private Limited (since 2017), and holds 1 more current directorship. The companies operate in Pharma and Travel and Hospitality. The 4 current companies with reported revenue have a combined latest revenue of ₹77.64 Cr; the largest is S.G.Biopharm Private Limited at ₹45.39 Cr (FY 2025). Earlier, Anand Ganpatbhai Trivedi was a Director at Pharmachem Lifesciences Private Limited (from 2019).

DIN 03040899
Primary Designation Director
Industry Pharma
First Appointment 11 Oct 2017
Oldest Company Age 10 yrs
Largest company S.G.Biopharm Private Limited · ₹45.39 Cr (FY 2025)
Combined revenue ₹77.64 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
S.G.Biopharm Private Limited U24299MH2018PTC312547
Director07 Aug 20182018₹45.39 Cr (FY 2025)Active
Designated Partner05 Mar 20202016₹21.95 Cr (FY 2024)Active
Director11 Oct 20172017₹6.79 Cr (FY 2025)Active
Sunders Kitchen Private Limited U55109MH2021PTC354382
Director24 Feb 20242021₹3.52 Cr (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Dec 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Pharmachem Lifesciences Private Limited
S.G.Biopharm Private Limited
Pharmachem Biotech (I) Private Limited
Ambix Healthcare Llp
Premium access

Shareholding and investment profile for Anand Ganpatbhai Trivedi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anand Ganpatbhai Trivedi

Anand Ganpatbhai Trivedi currently holds 4 directorships: S.G.Biopharm Private Limited (Director, since 07 Aug 2018, revenue ₹45.39 Cr (FY 2025)); Ambix Healthcare Llp (Designated Partner, since 05 Mar 2020, revenue ₹21.95 Cr (FY 2024)); Pharmachem Biotech (I) Private Limited (Director, since 11 Oct 2017, revenue ₹6.79 Cr (FY 2025)); Sunders Kitchen Private Limited (Director, since 24 Feb 2024, revenue ₹3.52 Cr (FY 2024)).

Anand Ganpatbhai Trivedi was first appointed on 11 Oct 2017 as Director at Pharmachem Biotech (I) Private Limited. The most recent appointment on record is 24 Feb 2024 at Sunders Kitchen Private Limited.

The 4 current companies of Anand Ganpatbhai Trivedi that report revenue have a combined latest revenue of ₹77.64 Cr: S.G.Biopharm Private Limited ₹45.39 Cr (FY 2025); Ambix Healthcare Llp ₹21.95 Cr (FY 2024); Pharmachem Biotech (I) Private Limited ₹6.79 Cr (FY 2025); Sunders Kitchen Private Limited ₹3.52 Cr (FY 2024).

Anand Ganpatbhai Trivedi held 1 earlier board appointment: Pharmachem Lifesciences Private Limited (Director, from 17 Dec 2019).

The current boards of Anand Ganpatbhai Trivedi's companies include Amitkumar Ganpatbhai Trivedi (S.G.Biopharm Private Limited), Niraj Harshad Dholakiya (S.G.Biopharm Private Limited), Yogesh Hareshkumar Patel (Ambix Healthcare Llp), Hersal Bharat Parmar (Pharmachem Biotech (I) Private Limited), Prashant Sunder Shetty (Sunders Kitchen Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available